Screening and identification of plasma lncRNAs uc.48+ and NR_105053 as potential novel biomarkers for cured pulmonary tuberculosis

In 2018, there were about 10 million new tuberculosis (TB) cases and 1.24 million TB deaths worldwide. China is ranked second for TB disease burden in the world with estimated 866,000 new TB patients and 37,000 TB related deaths annually (World Health Organization, 2019). One of the reasons for the high incidence of TB is the early discharge of uncured patients who can cause disease transmission. At present, cured TB is mainly evaluated by the following standards: ① Whether the patient has received standardized anti-TB treatment; ② Chest X-ray and/or CT scan results; ③ Sputum smear and sputum culture results.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research